Long-Term Follow-Up of Transsexual Persons Undergoing Sex Reassignment Surgery: Cohort Study in Sweden by Dhejne, Cecilia et al.
Long-Term Follow-Up of Transsexual Persons
Undergoing Sex Reassignment Surgery: Cohort Study in
Sweden
Cecilia Dhejne
1, Paul Lichtenstein
2, Marcus Boman
2, Anna L. V. Johansson
2, Niklas La ˚ngstro ¨m
2,3, Mikael
Lande ´n
1,2,4*
1Department of Clinical Neuroscience, Division of Psychiatry, Karolinska Institutet, Stockholm, Sweden, 2Department of Medical Epidemiology and Biostatistics,
Karolinska Institutet, Stockholm, Sweden, 3Centre for Violence Prevention, Karolinska Institutet, Stockholm, Sweden, 4Institute of Neuroscience and Physiology, The
Sahlgrenska Academy at Gothenburg University, Gothenburg, Sweden
Abstract
Context: The treatment for transsexualism is sex reassignment, including hormonal treatment and surgery aimed at making
the person’s body as congruent with the opposite sex as possible. There is a dearth of long term, follow-up studies after sex
reassignment.
Objective: To estimate mortality, morbidity, and criminal rate after surgical sex reassignment of transsexual persons.
Design: A population-based matched cohort study.
Setting: Sweden, 1973-2003.
Participants: All 324 sex-reassigned persons (191 male-to-females, 133 female-to-males) in Sweden, 1973–2003. Random
population controls (10:1) were matched by birth year and birth sex or reassigned (final) sex, respectively.
Main Outcome Measures: Hazard ratios (HR) with 95% confidence intervals (CI) for mortality and psychiatric morbidity were
obtained with Cox regression models, which were adjusted for immigrant status and psychiatric morbidity prior to sex
reassignment (adjusted HR [aHR]).
Results: The overall mortality for sex-reassigned persons was higher during follow-up (aHR 2.8; 95% CI 1.8–4.3) than for
controls of the same birth sex, particularly death from suicide (aHR 19.1; 95% CI 5.8–62.9). Sex-reassigned persons also had
an increased risk for suicide attempts (aHR 4.9; 95% CI 2.9–8.5) and psychiatric inpatient care (aHR 2.8; 95% CI 2.0–3.9).
Comparisons with controls matched on reassigned sex yielded similar results. Female-to-males, but not male-to-females,
had a higher risk for criminal convictions than their respective birth sex controls.
Conclusions: Persons with transsexualism, after sex reassignment, have considerably higher risks for mortality, suicidal
behaviour, and psychiatric morbidity than the general population. Our findings suggest that sex reassignment, although
alleviating gender dysphoria, may not suffice as treatment for transsexualism, and should inspire improved psychiatric and
somatic care after sex reassignment for this patient group.
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Introduction
Transsexualism (ICD-10),[1] or gender identity disorder (DSM-
IV),[2] is a condition in which a person’s gender identity - the sense
of being a man or a woman - contradicts his or her bodily sex
characteristics. The individual experiences gender dysphoria and
desires to live and be accepted as a member of the opposite sex.
The treatment for transsexualism includes removal of body hair,
vocal training, and cross-sex hormonal treatment aimed at making
the person’s body as congruent with the opposite sex as possible to
alleviate the gender dysphoria. Sex reassignment also involves the
surgical removal of body parts to make external sexual
characteristics resemble those of the opposite sex, so called sex
reassignment/confirmation surgery (SRS). This is a unique
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present form of sex reassignment has been practised for more than
half a century and is the internationally recognized treatment to
ease gender dysphoria in transsexual persons.[3,4]
Despite the long history of this treatment, however, outcome
data regarding mortality and psychiatric morbidity are scant. With
respect to suicide and deaths from other causes after sex
reassignment, an early Swedish study followed 24 transsexual
persons for an average of six years and reported one suicide.[5] A
subsequent Swedish study recorded three suicides after sex
reassignment surgery of 175 patients.[6] A recent Swedish
follow-up study reported no suicides in 60 transsexual patients,
but one death due to complications after the sex reassignment
surgery.[7] A Danish study reported death by suicide in 3 out of 29
operated male-to-female transsexual persons followed for an
average of six years.[8] By contrast, a Belgian study of 107
transsexual persons followed for 4–6 years found no suicides or
deaths from other causes.[9] A large Dutch single-centre study
(N=1,109), focusing on adverse events following hormonal
treatment, compared the outcome after cross-sex hormone
treatment with national Dutch standardized mortality and
morbidity rates and found no increased mortality, with the
exception of death from suicide and AIDS in male-to-females 25–
39 years of age.[10] The same research group concluded in a
recent report that treatment with cross-sex hormones seems
acceptably safe, but with the reservation that solid clinical data are
missing.[11] A limitation with respect to the Dutch cohort is that
the proportion of patients treated with cross-sex hormones who
also had surgical sex-reassignment is not accounted for.[10]
Data is inconsistent with respect to psychiatric morbidity post
sex reassignment. Although many studies have reported psychiat-
ric and psychological improvement after hormonal and/or
surgical treatment,[7,12,13,14,15,16] other have reported on
regrets,[17] psychiatric morbidity, and suicide attempts after
SRS.[9,18] A recent systematic review and meta-analysis con-
cluded that approximately 80% reported subjective improvement
in terms of gender dysphoria, quality of life, and psychological
symptoms, but also that there are studies reporting high
psychiatric morbidity and suicide rates after sex reassignment.[19]
The authors concluded though that the evidence base for sex
reassignment ‘‘is of very low quality due to the serious
methodological limitations of included studies.’’
The methodological shortcomings have many reasons. First, the
nature of sex reassignment precludes double blind randomized
controlled studies of the result. Second, transsexualism is rare [20]
and many follow-ups are hampered by small numbers of
subjects.[5,8,21,22,23,24,25,26,27,28] Third, many sex reassigned
persons decline to participate in follow-up studies, or relocate after
surgery, resulting in high drop-out rates and consequent selection
bias.[6,9,12,21,24,28,29,30] Forth, several follow-up studies are
hampered by limited follow-up periods.[7,9,21,22,26,30] Taken
together, these limitations preclude solid and generalisable
conclusions. A long-term population-based controlled study is
one way to address these methodological shortcomings.
Here, we assessed mortality, psychiatric morbidity, and psycho-
social integration expressed in criminal behaviour after sex
reassignment in transsexual persons, in a total population cohort
study with long-term follow-up information obtained from Swedish
registers. The cohort was compared with randomly selected
population controls matched for age and gender. We adjusted for
premorbid differences regarding psychiatric morbidity and immi-
grant status. This study design sheds new light on transsexual
persons’ health after sex reassignment. It does not, however, address
whether sex reassignment is an effective treatment or not.
Methods
National registers
The study population was identified by the linkage of several
Swedish national registers, which contained a total of 13.8 million
unique individuals. The Hospital Discharge Register (HDR, held
by the National Board of Health and Welfare) contains discharge
diagnoses, up to seven contributory diagnoses, external causes of
morbidity or mortality, surgical procedure codes, and discharge
date. Discharge diagnoses are coded according to the 8
th
(1969-1986), 9
th (1987–1996), and 10
th editions (1997-) of the
International Classification of Diseases (ICD). The register covers
virtually all psychiatric inpatient episodes in Sweden since 1973.
Discharges that occurred up to 31 December 2003 were included.
Surgical procedure codes could not be used for this study due to
the lack of a specific code for sex reassignment surgery. The Total
Population Register (TPR, held by Statistics Sweden) is comprised
of data about the entire Swedish population. Through linkage with
the Total Population Register it was possible to identify birth date
and birth gender for all study subjects. The register is updated
every year and gender information was available up to 2004/2005.
The Medical Birth Register (MBR) was established in 1973 and
contains birth data, including gender of the child at birth. National
censuses based on mandatory self-report questionnaires completed
by all adult citizens in 1960, 1970, 1980, and 1990 provided
information on individuals, households, and dwellings, including
gender, living area, and highest educational level. Complete
migration data, including country of birth for immigrants for
1969–2003, were obtained from the TPR. In addition to
educational information from the censuses, we also obtained
highest educational level data for 1990 and 2000 from the Register
of Education. The Cause of Death Register (CDR, Statistics
Sweden) records all deaths in Sweden since 1952 and provided
information on date of death and causes of death. Death events
occurring up to 31 December 2003 are included in the study. The
Crime Register (held by the National Council of Crime
Prevention) provided information regarding crime type and date
on all criminal convictions in Sweden during the period 1973–
2004. Attempted and aggravated forms of all offences were also
included. All crimes in Sweden are registered regardless of insanity
at the time of perpetration; for example, for individuals who
suffered from psychosis at the time of the offence. Moreover,
conviction data include individuals who received custodial or non-
custodial sentences and cases where the prosecutor decided to
caution or fine without court proceedings. Finally, Sweden does
not differ considerably from other members of the European
Union regarding rates of violent crime and their resolution.[31]
Study population, identification of sex-reassigned
persons (exposure assessment)
The study was designed as a population-based matched cohort
study. We used the individual national registration number,
assigned to all Swedish residents, including immigrants on arrival,
as the primary key through all linkages. The registration number
consists of 10 digits; the first six provide information of the birth
date, whereas the ninth digit indicates the gender. In Sweden, a
person presenting with gender dysphoria is referred to one of six
specialised gender teams that evaluate and treat patients
principally according to international consensus guidelines:
Standards of Care.[3] With a medical certificate, the person
applies to the National Board of Health and Welfare to receive
permission for sex reassignment surgery and a change of legal sex
status. A new national registration number signifying the new
gender is assigned after sex reassignment surgery. The National
Long-Term Follow-Up of Sex Reassignment
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new national registration numbers, making it possible to follow
individuals undergoing sex reassignment across registers and over
time. Hence, sex reassignment surgery in Sweden requires (i) a
transsexualism diagnosis and (ii) permission from the National
Board of Health and Welfare.
A person was defined as exposed to sex reassignment surgery if
two criteria were met: (i) at least one inpatient diagnosis of gender
identity disorder diagnosis without concomitant psychiatric
diagnoses in the Hospital Discharge Register, and (ii) at least
one discrepancy between gender variables in the Medical Birth
Register (from 1973 and onwards) or the National Censuses from
1960, 1970, 1980, or 1990 and the latest gender designation in the
Total Population Register. The first criterion was employed to
capture the hospitalization for sex reassignment surgery that serves
to secure the diagnosis and provide a time point for sex
reassignment surgery; the plastic surgeons namely record the
reason for sex reassignment surgery, i.e., transsexualism, but not
any co-occurring psychiatric morbidity. The second criterion was
used to ensure that the person went through all steps in sex-
reassignment and also changed sex legally.
The date of sex reassignment (start of follow-up) was defined as
the first occurrence of a gender identity disorder diagnosis, without
any other concomitant psychiatric disorder, in the Hospital
Discharge Register after the patient changed sex status (any
discordance in sex designation across the Censuses, Medical Birth,
and Total Population registers). If this information was missing, we
used instead the closest date in the Hospital Discharge Register on
which the patient was diagnosed with gender identity disorder
without concomitant psychiatric disorder prior to change in sex
status. The reason for prioritizing the use of a gender identity
disorder diagnosis after changed sex status over before was to avoid
overestimating person-years at risk of sex-reassigned person.
Using these criteria, a total of 804 patients with gender identity
disorder were identified, whereof 324 displayed a shift in the
gender variable during the period 1973–2003. The 480 persons
that did not shift gender variable comprise persons who either did
not apply, or were not approved, for sex reassignment surgery.
Moreover, the ICD 9 code 302 is a non specific code for sexual
disorders. Hence, this group might also comprise persons that
were hospitalized for sexual disorders other than transsexualism.
Therefore, they were omitted from further analyses. Of the
remaining 324 persons, 288 were identified with the gender
identity diagnosis after and 36 before change of sex status. Out of the
288 persons identified after changed sex status, 185 could also be
identified before change in sex status. The median time lag between
the hospitalization before and after sex change for these 185 persons
was 0.96 years (mean 2.2 years, SD 3.3).
Gender identity disorder was coded according to ICD-8: 302.3
(transsexualism) and 302.9 (sexual deviation NOS); ICD-9: 302
(overall code for sexual deviations and disorders, more specific
codes were not available in ICD-9); and ICD-10: F64.0
(transsexualism), F64.1 (dual-role transvestism), F64.8 (other
gender identity disorder), and F64.9 (gender identity disorder
NOS). Other psychiatric disorders were coded as ICD-8: 290-301
and 303-315; ICD-9: 290-301 and 303-319; and ICD-10: F00-F63
as well as F65-F99.
Identification of population-based controls (unexposed
group)
For each exposed person (N=324), we randomly selected 10
unexposed controls. A person was defined as unexposed if there
were no discrepancies in sex designation across the Censuses,
Medical Birth, and Total Population registers and no gender
identity disorder diagnosis according to the Hospital Discharge
Register. Control persons were matched by sex and birth year and
had to be alive and residing in Sweden at the estimated sex
reassignment date of the case person. To study possible gender-
specific effects on outcomes of interest, we used two different
control groups: one with the same sex as the case individual at
birth (birth sex matching) and the other with the sex that the case
individual had been reassigned to (final sex matching).
Outcome measures
We studied mortality, psychiatric morbidity, accidents, and
crime following sex reassignment. More specifically, we investi-
gated: (1) all-cause mortality, (2) death by definite/uncertain
suicide, (3) death by cardiovascular disease, and (4) death by
tumour. Morbidity included (5) any psychiatric disorder (gender
identity disorders excluded), (6) alcohol/drug misuse and depen-
dence, (7) definite/uncertain suicide attempt, and (8) accidents.
Finally, we addressed court convictions for (9) any criminal offence
and (10) any violent offence. Each individual could contribute with
several outcomes, but only one event per outcome. Causes of
death (Cause of Death Registry from 1952 and onwards) were
defined according to ICD as suicide (ICD-8 and ICD-9 codes
E950-E959 and E980-E989, ICD-10 codes X60-X84 and Y10-
Y34); cardiovascular disease (ICD-8 codes 390-458, ICD-9 codes
390-459, ICD-10 codes I00-I99); neoplasms (ICD-8 and ICD-9
codes 140-239, ICD-10 codes C00-D48), any psychiatric disorder
(gender identity disorders excluded); (ICD-8 codes 290-301 and
303-315, ICD-9 codes 290-301 and 303-319, ICD-10 codes F00-
F63 and F65-F99); alcohol/drug abuse and dependence (ICD-8
codes 303-304, ICD-9 codes 303-305 (tobacco use disorder
excluded), ICD-10 codes F10-F16 and F18-F19 (x5 excluded);
and accidents (ICD-8 and ICD-9 codes E800-E929, ICD-10 codes
V01-X59).
Any criminal conviction during follow-up was counted;
specifically, violent crime was defined as homicide and attempted
homicide, aggravated assault and assault, robbery, threatening
behaviour, harassment, arson, or any sexual offense.[32]
Covariates
Severe psychiatric morbidity was defined as inpatient care
according to ICD-8 codes 291, 295-301, 303-304, and 307; ICD-9
codes 291-292, 295-298, 300-301, 303-305 (tobacco use disorder
excluded), 307.1, 307.5, 308-309, and 311; ICD-10 codes F10-
F16, F18-F25, F28-F45, F48, F50, and F60-F62. Immigrant status,
defined as individuals born abroad, was obtained from the Total
Population Register. All outcome/covariate variables were
dichotomized (i.e., affected or unaffected) and without missing
values.
Statistical analyses
Each individual contributed person-time from study entry (for
exposed: date of sex reassignment; for unexposed: date of sex
reassignment of matched case) until date of outcome event, death,
emigration, or end of study period (31 December 2003), whichever
came first. The association between exposure (sex reassignment)
and outcome (mortality, morbidity, crime) was measured by
hazard ratios (HR) with 95% CIs, taking follow-up time into
account. HRs were estimated from Cox proportional hazard
regression models, stratified on matched sets (1:10) to account for
the matching by sex, age, and calendar time (birth year). We
present crude HRs (though adjusted for sex and age through
matching) and confounder-adjusted HRs [aHRs] for all outcomes.
The two potential confounders, immigrant status (yes/no) and
history of severe psychiatric morbidity (yes/no) prior to sex
Long-Term Follow-Up of Sex Reassignment
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different prevalence across cases and controls (Table 1).
Gender-separated analyses were performed and a Kaplan-
Meier survival plot graphically illustrates the survival of the sex
reassigned cohort and matched controls (all-cause mortality) over
time. The significance level was set at 0.05 (all tests were two-
sided). All outcome/covariate variables were without missing
values, since they are generated from register data, which are
either present (affected) or missing (unaffected). The data were
analysed using SAS version 9.1 (SAS Institute Inc., Cary, NC,
USA).
Ethics
The data linking of national registers required for this study was
approved by the IRB at Karolinska Institutet, Stockholm. All data
were analyzed anonymously; therefore, informed consent for each
individual was neither necessary nor possible.
Results
We identified 324 transsexual persons (exposed cohort) who
underwent sex reassignment surgery and were assigned a new legal
sex between 1973 and 2003. These constituted the sex-reassigned
(exposed) group. Fifty-nine percent (N=191) of sex-reassigned
persons were male-to-females and 41% (N=133) female-to-males,
yielding a sex ratio of 1.4:1 (Table 1).
The average follow-up time for all-cause mortality was 11.4
(median 9.1) years. The average follow-up time for the risk of
being hospitalized for any psychiatric disorder was 10.4 (median
8.1).
Characteristics prior to sex reassignment
Table 1 displays demographic characteristics of sex-reassigned
and control persons prior to study entry (sex reassignment). There
were no substantial differences between female-to-males and male-
to-females regarding measured baseline characteristics. Immigrant
status was twice as common among transsexual individuals
compared to controls, living in an urban area somewhat more
common, and higher education about equally prevalent. Trans-
sexual individuals had been hospitalized for psychiatric morbidity
other than gender identity disorder prior to sex reassignment
about four times more often than controls. To adjust for these
baseline discrepancies, hazard ratios adjusted for immigrant status
and psychiatric morbidity prior to baseline are presented for all
outcomes [aHRs].
Mortality
Table 2 describes the risks for selected outcomes during follow-up
among sex-reassigned persons, compared to same-age controls of
the same birth sex. Sex-reassigned transsexual persons of both
genders had approximately a three times higher risk of all-cause
mortality than controls, also after adjustment for covariates. Table 2
Table 1. Baseline characteristics among sex-reassigned subjects in Sweden (N=324) and population controls matched for birth
year and sex.
Characteristic at baseline
Sex-reassigned subjects
(N=324)
Birth-sex matched controls
(N=3,240)
Final-sex matched controls
(N=3,240)
Gender
Female at birth, male after sex change 133 (41%) 1,330 (41%) 1,330 (41%)
Male at birth, female after sex change 191 (59%) 1,910 (59%) 1,910 (59%)
Average age at study entry [years] (SD, min-max)
Female at birth, male after sex change 33.3 (8.7, 20–62) 33.3 (8.7, 20–62) 33.3 (8.7, 20–62)
Male at birth, female after sex change 36.3 (10.1, 21–69) 36.3 (10.1, 21–69) 36.3 (10.1, 21–69)
Both genders 35.1 (9.7, 20–69) 35.1 (9.7, 20–69) 35.1 (9.7, 20–69)
Immigrant status
Female at birth, male after sex change 28 (21%) 118 (9%) 100 (8%)
Male at birth, female after sex change 42 (22%) 176 (9%) 164 (9%)
Both genders 70 (22%) 294 (9%) 264 (8%)
Less than 10 years of schooling prior to entry vs. 10 years or more
Females at birth, males after sex change 49 (44%); 62 (56%) 414 (37%); 714 (63%) 407 (36%); 713 (64%)
Males at birth, females after sex change 61 (41%); 89 (59%) 665 (40%); 1,011 (60%) 595 (35%); 1,091 (65%)
All individuals with data 110 (42%); 151 (58%) 1,079 (38%); 1,725 (62%) 1,002 (36%); 1,804 (64%)
Psychiatric morbidity* prior to study entry
Female at birth, male after sex change 22 (17%) 47 (4%) 42 (3%)
Male at birth, female after sex change 36 (19%) 76 (4%) 72 (4%)
Both genders 58 (18%) 123 (4%) 114 (4%)
Rural [vs. urban] living area prior to entry
Female at birth, male after sex change 13 (10%) 180 (14%) 195 (15%)
Male at birth, female after sex change 20 (10%) 319 (17%) 272 (14%)
Both genders 33 (10%) 499 (15%) 467 (14%)
Note:
*Hospitalizations for gender identity disorder were not included.
doi:10.1371/journal.pone.0016885.t001
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was performed: during the period 1973-1988 or 1989–2003. Even
though the overall mortality was increased across both time periods,
it did not reach statistical significance for the period 1989–2003.
The Kaplan-Meier curve (Figure 1) suggests that survival of
transsexual persons started to diverge from that of matched controls
after about 10 years of follow-up. The cause-specific mortality from
suicide was much higher in sex-reassigned persons, compared to
matched controls. Mortality due to cardiovascular disease was
moderately increased among the sex-reassigned, whereas the
numerically increased risk for malignancies was borderline
statistically significant. The malignancies were lung cancer (N=3),
tongue cancer (N=1), pharyngeal cancer (N=1), pancreas cancer
(N=1), liver cancer (N=1), and unknown origin (N=1).
Figure 1. Death from any cause as a function of time after sex reassignment among 324 transsexual persons in Sweden (male-to-
female: N=191, female-to-male: N=133), and population controls matched on birth year.
doi:10.1371/journal.pone.0016885.g001
Table 2. Risk of various outcomes among sex-reassigned subjects in Sweden (N=324) compared to population controls matched
for birth year and birth sex.
Number of events
cases/
controls
1973–2003
Outcome incidence rate
per 1000 person-years
1973–2003
(95% CI)
Crude
hazard ratio
(95% CI)
1973–2003
Adjusted*
hazard ratio
(95% CI)
1973–2003
Adjusted*
hazard ratio
(95% CI)
1973–1988
Adjusted*
hazard ratio
(95% CI)
1989–2003
Cases Controls
Any death 27/99 7.3 (5.0–10.6) 2.5 (2.0–3.0) 2.9 (1.9–4.5) 2.8 (1.8–4.3) 3.1 (1.9–5.0) 1.9 (0.7–5.0)
Death by suicide 10/5 2.7 (1.5–5.0) 0.1 (0.1–0.3) 19.1 (6.5–55.9) 19.1 (5.8–62.9) N/A N/A
Death by cardiovascular
disease
9/42 2.4 (1.3–4.7) 1.1 (0.8–1.4) 2.6 (1.2–5.4) 2.5 (1.2–5.3) N/A N/A
Death by neoplasm 8/38 2.2 (1.1–4.3) 1.0 (0.7–1.3) 2.1 (1.0–4.6) 2.1 (1.0–4.6) N/A N/A
Any psychiatric
hospitalisation{
64/173 19.0 (14.8–24.2) 4.2 (3.6–4.9) 4.2 (3.1–5.6) 2.8 (2.0–3.9) 3.0 (1.9–4.6) 2.5 (1.4–4.2)
Substance misuse 22/78 5.9 (3.9–8.9) 1.8 (1.5–2.3) 3.0 (1.9–4.9) 1.7 (1.0–3.1) N/A N/A
Suicide attempt 29/44 7.9 (5.5–11.4) 1.0 (0.8–1.4) 7.6 (4.7–12.4) 4.9 (2.9–8.5) 7.9 (4.1–15.3) 2.0 (0.7–5.3)
Any accident 32/233 9.0 (6.3–12.7) 5.7 (5.0–6.5) 1.6 (1.1–2.3) 1.4 (1.0–2.1) 1.6 (1.0–2.5) 1.1 (0.5–2.2)
Any crime 60/350 18.5 (14.3–23.8) 9.0 (8.1–10.0) 1.9 (1.4–2.5) 1.3 (1.0–1.8) 1.6 (1.1–2.4) 0.9 (0.6–1.5)
Violent crime 14/61 3.6 (2.1–6.1) 1.4 (1.1–1.8) 2.7 (1.5–4.9) 1.5 (0.8–3.0) N/A N/A
Notes:
*Adjusted for psychiatric morbidity prior to baseline and immigrant status.
{Hospitalisations for gender identity disorder were excluded.
N/A Not applicable due to sparse data.
doi:10.1371/journal.pone.0016885.t002
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Sex-reassigned persons had a higher risk of inpatient care for a
psychiatric disorder other than gender identity disorder than
controls matched on birth year and birth sex (Table 2). This held
after adjustment for prior psychiatric morbidity, and was true
regardless of whether sex reassignment occurred before or after
1989. In line with the increased mortality from suicide, sex-
reassigned individuals were also at a higher risk for suicide
attempts, though this was not statistically significant for the time
period 1989–2003. The risks of being hospitalised for substance
misuse or accidents were not significantly increased after adjusting
for covariates (Table 2).
Crime rate
Transsexual individuals were at increased risk of being
convicted for any crime or violent crime after sex reassignment
(Table 2); this was, however, only significant in the group who
underwent sex reassignment before 1989.
Gender differences
Comparisons of female-to-males and male-to-females, although
hampered by low statistical power and associated wide confidence
intervals, suggested mostly similar risks for adverse outcomes
(Tables S1 and S2). However, violence against self (suicidal
behaviour) and others ([violent] crime) constituted important
exceptions. First, male-to-females had significantly increased risks
for suicide attempts compared to both female (aHR 9.3; 95% CI
4.4–19.9) and male (aHR 10.4; 95% CI 4.9–22.1) controls. By
contrast, female-to-males had significantly increased risk of suicide
attempts only compared to male controls (aHR 6.8; 95% CI 2.1–
21.6) but not compared to female controls (aHR 1.9; 95% CI 0.7–
4.8). This suggests that male-to-females are at higher risk for
suicide attempts after sex reassignment, whereas female-to-males
maintain a female pattern of suicide attempts after sex reassign-
ment (Tables S1 and S2).
Second, regarding any crime, male-to-females had a signifi-
cantly increased risk for crime compared to female controls (aHR
6.6; 95% CI 4.1–10.8) but not compared to males (aHR 0.8; 95%
CI 0.5–1.2). This indicates that they retained a male pattern
regarding criminality. The same was true regarding violent crime.
By contrast, female-to-males had higher crime rates than female
controls (aHR 4.1; 95% CI 2.5–6.9) but did not differ from male
controls. This indicates a shift to a male pattern regarding
criminality and that sex reassignment is coupled to increased crime
rate in female-to-males. The same was true regarding violent
crime.
Discussion
Principal findings and comparison with previous research
We report on the first nationwide population-based, long-term
follow-up of sex-reassigned transsexual persons. We compared our
cohort with randomly selected population controls matched for
age and gender. The most striking result was the high mortality
rate in both male-to-females and female-to males, compared to the
general population. This contrasts with previous reports (with one
exception[8]) that did not find an increased mortality rate after sex
reassignment, or only noted an increased risk in certain
subgroups.[7,9,10,11] Previous clinical studies might have been
biased since people who regard their sex reassignment as a failure
are more likely to be lost to follow-up. Likewise, it is cumbersome
to track deceased persons in clinical follow-up studies. Hence,
population-based register studies like the present are needed to
improve representativity.[19,34]
The poorer outcome in the present study might also be
explained by longer follow-up period (median .10 years)
compared to previous studies. In support of this notion, the
survival curve (Figure 1) suggests increased mortality from ten
years after sex reassignment and onwards. In accordance, the
overall mortality rate was only significantly increased for the group
operated before 1989. However, the latter might also be explained
by improved health care for transsexual persons during 1990s,
along with altered societal attitudes towards persons with different
gender expressions.[35]
Mortality due to cardiovascular disease was significantly
increased among sex reassigned individuals, albeit these results
should be interpreted with caution due to the low number of
events. This contrasts, however, a Dutch follow-up study that
reported no increased risk for cardiovascular events.[10,11] A
recent meta-analysis concluded, however, that data on cardiovas-
cular outcome after cross-sex steroid use are sparse, inconclusive,
and of very low quality.[34]
With respect to neoplasms, prolonged hormonal treatment
might increase the risk for malignancies,[36] but no previous study
has tested this possibility. Our data suggested that the cause-
specific risk of death from neoplasms was increased about twice
(borderline statistical significance). These malignancies (see
Results), however, are unlikely to be related to cross-hormonal
treatment.
There might be other explanations to increased cardiovascular
death and malignancies. Smoking was in one study reported in
almost 50% by the male-to females and almost 20% by female-to-
males.[9] It is also possible that transsexual persons avoid the
health care system due to a presumed risk of being discriminated.
Mortality from suicide was strikingly high among sex-reassigned
persons, also after adjustment for prior psychiatric morbidity. In
line with this, sex-reassigned persons were at increased risk for
suicide attempts. Previous reports [6,8,10,11] suggest that
transsexualism is a strong risk factor for suicide, also after sex
reassignment, and our long-term findings support the need for
continued psychiatric follow-up for persons at risk to prevent this.
Inpatient care for psychiatric disorders was significantly more
common among sex-reassigned persons than among matched
controls, both before and after sex reassignment. It is generally
accepted that transsexuals have more psychiatric ill-health than the
general population prior to the sex reassignment.[18,21,22,33] It
should therefore come as no surprise that studies have found high
rates of depression,[9] and low quality of life[16,25] also after sex
reassignment. Notably, however, in this study the increased risk for
psychiatric hospitalisation persisted even after adjusting for psychi-
atric hospitalisation prior to sex reassignment. This suggests that
even though sex reassignment alleviates gender dysphoria, there is a
need to identify and treat co-occurring psychiatric morbidity in
transsexual persons not only before but also after sex reassignment.
Criminal activity, particularly violent crime, is much more
common among men than women in the general population. A
previous study of all applications for sex reassignment in Sweden
up to 1992 found that 9.7% of male-to-female and 6.1% of female-
to-male applicants had been prosecuted for a crime.[33] Crime
after sex reassignment, however, has not previously been studied.
In this study, male-to-female individuals had a higher risk for
criminal convictions compared to female controls but not
compared to male controls. This suggests that the sex reassignment
procedure neither increased nor decreased the risk for criminal
offending in male-to-females. By contrast, female-to-males were at
a higher risk for criminal convictions compared to female controls
and did not differ from male controls, which suggests increased
crime proneness in female-to-males after sex reassignment.
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Strengths of this study include nationwide representativity over
more than 30 years, extensive follow-up time, and minimal loss to
follow-up. Many previous studies suffer from low outcome
ascertainment,[6,9,21,29] whereas this study has captured almost
the entire population of sex-reassigned transsexual individuals in
Sweden from 1973–2003. Moreover, previous outcome studies
have mixed pre-operative and post-operative transsexual per-
sons,[22,37] while we included only post-operative transsexual
persons that also legally changed sex. Finally, whereas previous
studies either lack a control group or use standardised mortality
rates or standardised incidence rates as comparisons,[9,10,11] we
selected random population controls matched by birth year, and
either birth or final sex.
Given the nature of sex reassignment, a double blind
randomized controlled study of the result after sex reassignment
is not feasible. We therefore have to rely on other study designs.
For the purpose of evaluating whether sex reassignment is an
effective treatment for gender dysphoria, it is reasonable to
compare reported gender dysphoria pre and post treatment. Such
studies have been conducted either prospectively[7,12] or
retrospectively,[5,6,9,22,25,26,29,38] and suggest that sex reas-
signment of transsexual persons improves quality of life and
gender dysphoria. The limitation is of course that the treatment
has not been assigned randomly and has not been carried out
blindly.
For the purpose of evaluating the safety of sex reassignment in
terms of morbidity and mortality, however, it is reasonable to
compare sex reassigned persons with matched population controls.
The caveat with this design is that transsexual persons before sex
reassignment might differ from healthy controls (although this bias
can be statistically corrected for by adjusting for baseline
differences). It is therefore important to note that the current
study is only informative with respect to transsexuals persons
health after sex reassignment; no inferences can be drawn as to the
effectiveness of sex reassignment as a treatment for transsexualism.
In other words, the results should not be interpreted such as sex
reassignment per se increases morbidity and mortality. Things
might have been even worse without sex reassignment. As an
analogy, similar studies have found increased somatic morbidity,
suicide rate, and overall mortality for patients treated for bipolar
disorder and schizophrenia.[39,40] This is important information,
but it does not follow that mood stabilizing treatment or
antipsychotic treatment is the culprit.
Other facets to consider are first that this study reflects the
outcome of psychiatric and somatic treatment for transsexualism
provided in Sweden during the 1970s and 1980s. Since then,
treatment has evolved with improved sex reassignment surgery,
refined hormonal treatment,[11,41] and more attention to
psychosocial care that might have improved the outcome. Second,
transsexualism is a rare condition and Sweden is a small country
(9.2 million inhabitants in 2008). Hence, despite being based on a
comparatively large national cohort and long-term follow-up, the
statistical power was limited. Third, regarding psychiatric
morbidity after sex reassignment, we assessed inpatient psychiatric
care. Since most psychiatric care is provided in outpatient settings
(for which no reliable data were available), underestimation of the
absolute prevalences was inevitable. However, there is no reason to
believe that this would change the relative risks for psychiatric
morbidity unless sex-reassigned transsexual individuals were more
likely than matched controls to be admitted to hospital for any
given psychiatric condition.
Finally, to estimate start of follow-up, we prioritized using the
date of a gender identity disorder diagnosis after changed sex status
over before changed sex status, in order to avoid overestimating
person-years at risk after sex-reassignment. This means that
adverse outcomes might have been underestimated. However,
given that the median time lag between the hospitalization before
and after change of sex status was less than a year (see Methods),
this maneuver is unlikely to have influenced the results
significantly. Moreover, all deaths will be recorded regardless of
this exercise and mortality hence correctly estimated.
Conclusion
This study found substantially higher rates of overall mortality,
death from cardiovascular disease and suicide, suicide attempts,
and psychiatric hospitalisations in sex-reassigned transsexual
individuals compared to a healthy control population. This
highlights that post surgical transsexuals are a risk group that
need long-term psychiatric and somatic follow-up. Even though
surgery and hormonal therapy alleviates gender dysphoria, it is
apparently not sufficient to remedy the high rates of morbidity and
mortality found among transsexual persons. Improved care for the
transsexual group after the sex reassignment should therefore be
considered.
Supporting Information
Table S1 Risk of various outcomes in sex-reassigned
persons in Sweden compared to population controls
matched for birth year and birth sex.
(DOCX)
Table S2 Risk of various outcomes in sex-reassigned
persons in Sweden compared to controls matched for
birth year and final sex.
(DOCX)
Author Contributions
Conceived and designed the experiments: CD PL AJ NL ML. Performed
the experiments: MB AJ. Analyzed the data: CD PL MB AJ NL ML.
Contributed reagents/materials/analysis tools: PL NL AJ. Wrote the
paper: CD PL MB AJ NL ML.
References
1. World Health Organization (1993) The ICD-10 Classification of Mental and
Behavioural Disorders. Diagnostic criteria for research. Geneva: WHO.
2. American Psychiatric Association, ed (1994) Diagnostic and Statistical Manual of
Mental Disorders. Washington, DC: APA.
3. Meyer W, Bockting W, Cohen-Kettenis P, Coleman E, DiCeglie D, et al. (2002)
The Harry Benjamin International Gender Dysphoria Association’s Standards
of Care for Gender Identity Disorders, Sixth Version. Journal of Psychology &
Human Sexuality 13: 1–30.
4. Cohen-Kettenis PT, Gooren LJG (1999) Transsexualism: A review of etiology,
diagnosis and treatment. J Psychosom Res 46: 315–333.
5. Wa ˚linder J, Thuwe I (1975) A social-psychiatric follow-up study of 24 sex-
reassigned transsexuals. Go ¨teborg, Sweden: Scandinavian University Books.
6. Eldh J, Berg A, Gustafsson M (1997) Long-term follow up after sex reassignment
surgery. Scand J Plast Reconstr Surg Hand Surg 31: 39–45.
7. Johansson A, Sundbom E, Ho ¨jerback T, Bodlund O (2010) A five-year follow-up
study of Swedish adults with gender identity disorder. Arch Sex Behav 39:
1429–1437.
8. Sørensen T, Hertoft P (1982) Male and female transsexualism: the Danish
experience with 37 patients. ArchSex Behav 11: 133–155.
9. De CuypereG,T’Sjoen G,Beerten R,Selvaggi G,De SutterP, etal. (2005) Sexual
and physical health after sex reassignment surgery. Arch Sex Behav 34: 679–690.
10. van Kesteren PJ, Asscheman H, Megens JA, Gooren LJ (1997) Mortality and
morbidity in transsexual subjects treated with cross-sex hormones. Clin
Endocrinol Oxf 47: 337–342.
Long-Term Follow-Up of Sex Reassignment
PLoS ONE | www.plosone.org 7 February 2011 | Volume 6 | Issue 2 | e1688511. Gooren LJ, Giltay EJ, Bunck MC (2008) Long-term treatment of transsexuals
with cross-sex hormones: extensive personal experience. J Clin Endocrinol
Metab 93: 19–25.
12. Smith YL, van Goozen SH, Cohen-Kettenis PT (2001) Adolescents with gender
identity disorder who were accepted or rejected for sex reassignment surgery: a
prospective follow-up study. J Am Acad Child Adolesc Psychiatry 40: 472–481.
13. Smith YL, Van Goozen SH, Kuiper AJ, Cohen-Kettenis PT (2005) Sex
reassignment: outcomes and predictors of treatment for adolescent and adult
transsexuals. Psychol Med 35: 89–99.
14. Leavitt F, Berger JC, Hoeppner JA, Northrop G (1980) Presurgical adjustment
in male transsexuals with and without hormonal treatment. J Nerv Ment Dis
168: 693–697.
15. Cohen Kettenis PT, van Goozen SH (1997) Sex reassignment of adolescent
transsexuals: a follow-up study. J Am Acad Child Adolesc Psychiatry 36:
263–271.
16. Newfield E, Hart S, Dibble S, Kohler L (2006) Female-to-male transgender
quality of life. Qual Life Res 15: 1447–1457.
17. Lande ´n M, Wa ˚linder J, Hambert G, Lundstro ¨m B (1998) Factors predictive of
regret in sex reassignment. Acta Psychiatrica Scandinavica 97: 284–289.
18. Hepp U, Kraemer B, Schnyder U, Miller N, Delsignore A (2005) Psychiatric
comorbidity in gender identity disorder. J Psychosom Res 58: 259–261.
19. Murad MH, Elamin MB, Garcia MZ, Mullan RJ, Murad A, et al. (2010)
Hormonal therapy and sex reassignment: a systematic review and meta-analysis
of quality of life and psychosocial outcomes. Clin Endocrinol (Oxf) 72: 214–231.
20. Lande ´n M, Wa ˚linder J, Lundstro ¨m B (1996) Incidence and sex ratio of
transsexualism in Sweden. Acta Psychiatrica Scandinavica 93: 261–263.
21. Lobato MI, Koff WJ, Manenti C, da Fonseca Seger D, Salvador J, et al. (2006)
Follow-up of sex reassignment surgery in transsexuals: a Brazilian cohort. Arch
Sex Behav 35: 711–715.
22. Bodlund O, Kullgren G (1996) Transsexualism-General outcome and prognostic
factors. A five year follow-up study of 19 transsexuals in the process of changing
sex. Arch Sex Behav 25: 303–316.
23. Lindemalm G, Ko ¨rlin D, Uddenberg N (1986) Long-term follow-up of "sex
change" in 13 male-to-female transsexuals. Arch Sex Behav 15: 187–210.
24. Rauchfleisch U, Barth D, Battegay R (1998) [Results of long-term follow-up of
transsexual patients]. Nervenarzt 69: 799–805.
25. Kuhn A, Bodmer C, Stadlmayr W, Kuhn P, Mueller MD, et al. (2009) Quality
of life 15 years after sex reassignment surgery for transsexualism. Fertil Steril 92:
1685–1689 e1683.
26. Zimmermann A, Zimmer R, Kovacs L, Einodshofer S, Herschbach P, et al.
(2006) [Transsexuals’ life satisfaction after gender transformation operations].
Chirurg 77: 432–438.
27. Rehman J, Lazer S, Benet AE, Schaefer LC, Melman A (1999) The reported sex
and surgery satisfactions of 28 postoperative male-to- female transsexual
patients. Arch Sex Behav 28: 71–89.
28. Hepp U, Klaghofer R, Burkhard-Kubler R, Buddeberg C (2002) [Treatment
follow-up of transsexual patients. A catamnestic study]. Nervenarzt 73: 283–288.
29. Lawrence AA (2003) Factors associated with satisfaction or regret following
male-to-female sex reassignment surgery. Arch Sex Behav 32: 299–315.
30. Kaube H, Biemer E (1991) [Results of sex change operations in 30 transsexual
patients: psychosocial and sexual adaptation–surgical complications]. Handchir
Mikrochir Plast Chir 23: 276–278.
31. Dolme ´n L (2001) Brottsligheten i olika la ¨nder (Criminality in different countries).
Stockholm: Brottsfo ¨rebyggande ra ˚det (the Swedish National Council for Crime
Prevention).
32. Fazel S, Grann M (2006) The population impact of severe mental illness on
violent crime. Am J Psychiatry 163: 1397–1403.
33. Lande ´n M, Wa ˚linder J, Lundstro ¨m B (1998) Clinical characteristics of a total
cohort of female and male applicants for sex reassignment: a descriptive study.
Acta Psychiatrica Scandinavica 97: 189–194.
34. Elamin MB, Garcia MZ, Murad MH, Erwin PJ, Montori VM (2010) Effect of
sex steroid use on cardiovascular risk in transsexual individuals: a systematic
review and meta-analyses. Clin Endocrinol (Oxf) 72: 1–10.
35. Lande ´n M, Innala S (2000) Attitudes toward transsexualism in a Swedish
national survey. Archives of Sexual Behavior 29: 375–388.
36. Mueller A, Gooren L (2008) Hormone-related tumors in transsexuals receiving
treatment with cross-sex hormones. Eur J Endocrinol 159: 197–202.
37. Vujovic S, Popovic S, Sbutega-Milosevic G, Djordjevic M, Gooren L (2009)
Transsexualism in Serbia: a twenty-year follow-up study. J Sex Med 6:
1018–1023.
38. Rehman J, Lazer S, Benet AE, Schaefer LC, Melman A (1999) The reported sex
and surgery satisfactions of 28 postoperative male-to-female transsexual patients.
Arch Sex Behav 28: 71–89.
39. O ¨ sby U, Brandt L, Correia N, Ekbom A, Spare ´n P (2001) Excess mortality in
bipolar and unipolar disorder in Sweden. Arch Gen Psychiatry 58: 844–850.
40. Tidemalm D, Langstrom N, Lichtenstein P, Runeson B (2008) Risk of suicide
after suicide attempt according to coexisting psychiatric disorder: Swedish cohort
study with long term follow-up. Bmj 337: a2205.
41. Toorians AW, Thomassen MC, Zweegman S, Magdeleyns EJ, Tans G, et al.
(2003) Venous thrombosis and changes of hemostatic variables during cross-sex
hormone treatment in transsexual people. J Clin Endocrinol Metab 88:
5723–5729.
Long-Term Follow-Up of Sex Reassignment
PLoS ONE | www.plosone.org 8 February 2011 | Volume 6 | Issue 2 | e16885